Аналитика онлайн » BXRXV

Baudax Bio, Inc. develops and markets products for the hospital and other acute care settings. Baudax Bio, Inc. was formerly known as Recro Enterprises, Inc. The company was founded in 2019 and is based in Malvern, Pennsylvania. Baudax Bio, Inc. operates independently of Recro Pharma, Inc. as of November 21, 2019.

General
Code BXRXV
Type Common Stock
Name Baudax Bio Inc
Exchange NASDAQ
CurrencyCode USD
CurrencyName US Dollar
CurrencySymbol $
CountryName USA
CountryISO US
FiscalYearEnd December
Sector Other
Industry Other
IsDelisted Да
DelistedDate 2020-05-21
FullTimeEmployees 20
UpdatedAt 2020-06-14
Highlights
MarketCapitalization 40944940
MarketCapitalizationMln 40.9449
EPSEstimateCurrentYear 0
EPSEstimateNextYear 0
EPSEstimateNextQuarter 0
EPSEstimateCurrentQuarter 0
MostRecentQuarter 2019-09-30
ProfitMargin 0
OperatingMarginTTM 0
ReturnOnAssetsTTM 0
ReturnOnEquityTTM 0
RevenueTTM 0
RevenuePerShareTTM 0
QuarterlyRevenueGrowthYOY 0
GrossProfitTTM 0
DilutedEpsTTM 0
QuarterlyEarningsGrowthYOY 0

Financials / Income Statement / quarterly / net Income

-18.95M
2018-03-31
-18.95M
2018-06-30
-19.09M
2018-09-30
-7.46M
2019-03-31
-7.46M
2019-06-30
-10.32M
2019-09-30
Valuation
TrailingPE 0
ForwardPE 0
PriceSalesTTM 0
PriceBookMRQ 0
EnterpriseValue 0
EnterpriseValueRevenue 0
EnterpriseValueEbitda 0
SharesStats
SharesOutstanding 0
SharesFloat 0
PercentInsiders 0
PercentInstitutions 0
Technicals
52WeekHigh 0
52WeekLow 0
50DayMA 4.118
200DayMA 4.118
SharesShort 0
SharesShortPriorMonth 0
ShortRatio 0
ShortPercent 0
Financials
Balance_Sheet
currency_symbol USD
quarterly
2019-09-30
date 2019-09-30
currency_symbol USD
totalAssets 35985000.00
intangibleAssets 26400000.00
totalLiab 71408000.00
totalStockholderEquity -35423000.00
otherCurrentLiab 1498000.00
commonStock -35423000.00
otherLiab 65671000.00
goodWill 2127000.00
totalCurrentLiabilities 5217000.00
propertyPlantEquipment 5800000.00
totalCurrentAssets 1658000.00
netTangibleAssets -63950000.00
accountsPayable 361000.00
2019-06-30
date 2019-06-30
currency_symbol USD
totalAssets 38147000.00
intangibleAssets 26400000.00
totalLiab 67334000.00
totalStockholderEquity -29187000.00
otherCurrentLiab 1965000.00
commonStock -29187000.00
otherLiab 61762000.00
goodWill 2127000.00
totalCurrentLiabilities 4985000.00
propertyPlantEquipment 6034000.00
totalCurrentAssets 3586000.00
netTangibleAssets -57714000.00
accountsPayable 352000.00
2019-03-31
date 2019-03-31
currency_symbol USD
totalAssets 38147000.00
intangibleAssets 26400000.00
totalLiab 67334000.00
totalStockholderEquity -29187000.00
otherCurrentLiab 1965000.00
commonStock -29187000.00
otherLiab 61762000.00
goodWill 2127000.00
totalCurrentLiabilities 4985000.00
propertyPlantEquipment 6034000.00
totalCurrentAssets 3586000.00
netTangibleAssets -57714000.00
accountsPayable 352000.00
yearly
2018-12-31
date 2018-12-31
currency_symbol USD
totalAssets 35023000.00
intangibleAssets 26400000.00
totalLiab 103370000.00
totalStockholderEquity -68347000.00
otherCurrentLiab 15077000.00
commonStock -68347000.00
otherLiab 80590000.00
goodWill 2127000.00
totalCurrentLiabilities 22780000.00
propertyPlantEquipment 3982000.00
totalCurrentAssets 2514000.00
netTangibleAssets -96874000.00
accountsPayable 2653000.00
2017-12-31
date 2017-12-31
currency_symbol USD
totalAssets 32761000.00
intangibleAssets 26400000.00
totalLiab 95218000.00
totalStockholderEquity -62457000.00
otherCurrentLiab 32054000.00
commonStock -62457000.00
otherLiab 50468000.00
goodWill 2127000.00
totalCurrentLiabilities 44750000.00
propertyPlantEquipment 1766000.00
totalCurrentAssets 2468000.00
netTangibleAssets -90984000.00
accountsPayable 7155000.00
Cash_Flow
currency_symbol USD
quarterly
2019-09-30
date 2019-09-30
currency_symbol USD
changeToLiabilities 355000.00
totalCashflowsFromInvestingActivities -81000.00
totalCashFromFinancingActivities 3027000.00
changeToOperatingActivities 1930000.00
netIncome -10315000.00
totalCashFromOperatingActivities -2946000.00
depreciation 123000.00
changeToNetincome 4961000.00
capitalExpenditures 2000
2019-06-30
date 2019-06-30
currency_symbol USD
changeToLiabilities -3732000.00
totalCashflowsFromInvestingActivities -858500.00
totalCashFromFinancingActivities 20437500.00
changeToOperatingActivities -537500.00
netIncome -7458500.00
totalCashFromOperatingActivities -19579000.00
depreciation 123000.00
otherCashflowsFromFinancingActivities -5000000.00
changeToNetincome -7974000.00
capitalExpenditures 817500
2019-03-31
date 2019-03-31
currency_symbol USD
changeToLiabilities -3732000.00
totalCashflowsFromInvestingActivities -858500.00
totalCashFromFinancingActivities 20437500.00
changeToOperatingActivities -537500.00
netIncome -7458500.00
totalCashFromOperatingActivities -19579000.00
depreciation 123000.00
otherCashflowsFromFinancingActivities -5000000.00
changeToNetincome -7974000.00
capitalExpenditures 817500
2018-09-30
date 2018-09-30
currency_symbol USD
changeToLiabilities -2826000.00
totalCashflowsFromInvestingActivities -340000.00
totalCashFromFinancingActivities 15925000.00
changeToOperatingActivities 790000.00
netIncome -19092000.00
totalCashFromOperatingActivities -15585000.00
depreciation 161000.00
otherCashflowsFromFinancingActivities -5000000.00
changeToNetincome 5382000.00
capitalExpenditures 340000
2018-06-30
date 2018-06-30
currency_symbol USD
changeToLiabilities 760500.00
totalCashflowsFromInvestingActivities -930000.00
totalCashFromFinancingActivities 16561500.00
changeToOperatingActivities -10000.00
netIncome -18947000.00
totalCashFromOperatingActivities -15631500.00
depreciation 56000.00
otherCashflowsFromFinancingActivities -5000000.00
changeToNetincome 2509000.00
capitalExpenditures 889000
2018-03-31
date 2018-03-31
currency_symbol USD
changeToLiabilities 760500.00
totalCashflowsFromInvestingActivities -930000.00
totalCashFromFinancingActivities 16561500.00
changeToOperatingActivities -10000.00
netIncome -18947000.00
totalCashFromOperatingActivities -15631500.00
depreciation 56000.00
otherCashflowsFromFinancingActivities -5000000.00
changeToNetincome 2509000.00
capitalExpenditures 889000
yearly
2018-12-31
date 2018-12-31
currency_symbol USD
changeToLiabilities 493000.00
totalCashflowsFromInvestingActivities -3452000.00
totalCashFromFinancingActivities 63203000.00
changeToOperatingActivities -46000.00
netIncome -73667000.00
totalCashFromOperatingActivities -59751000.00
depreciation 396000.00
changeToNetincome 13073000.00
capitalExpenditures 3370000
2017-12-31
date 2017-12-31
currency_symbol USD
changeToLiabilities 2617000.00
totalCashflowsFromInvestingActivities -1287000.00
totalCashFromFinancingActivities 44559000.00
changeToOperatingActivities -1894000.00
netIncome -61084000.00
totalCashFromOperatingActivities -43272000.00
depreciation 72000.00
changeToNetincome 17017000.00
capitalExpenditures 768000
Income_Statement
currency_symbol USD
quarterly
2019-09-30
date 2019-09-30
currency_symbol USD
researchDevelopment 1845000.00
incomeBeforeTax -10315000.00
netIncome -10315000.00
sellingGeneralAdministrative 4524000.00
ebit -6369000.00
operatingIncome -6369000.00
totalOperatingExpenses 6369000.00
totalOtherIncomeExpenseNet -3946000.00
netIncomeFromContinuingOps -10315000.00
netIncomeApplicableToCommonShares -10315000.00
2019-06-30
date 2019-06-30
currency_symbol USD
researchDevelopment 6967000.00
incomeBeforeTax -7458500.00
netIncome -7458500.00
sellingGeneralAdministrative 6442000.00
ebit -13409000.00
operatingIncome -13409000.00
totalOperatingExpenses 13409000.00
totalOtherIncomeExpenseNet 5950500.00
netIncomeFromContinuingOps -7458500.00
netIncomeApplicableToCommonShares -7458500.00
2019-03-31
date 2019-03-31
currency_symbol USD
researchDevelopment 6967000.00
incomeBeforeTax -7458500.00
netIncome -7458500.00
sellingGeneralAdministrative 6442000.00
ebit -13409000.00
operatingIncome -13409000.00
totalOperatingExpenses 13409000.00
totalOtherIncomeExpenseNet 5950500.00
netIncomeFromContinuingOps -7458500.00
netIncomeApplicableToCommonShares -7458500.00
2018-09-30
date 2018-09-30
currency_symbol USD
researchDevelopment 9838000.00
incomeBeforeTax -19092000.00
netIncome -19092000.00
sellingGeneralAdministrative 5107000.00
ebit -14945000.00
operatingIncome -14945000.00
totalOperatingExpenses 14945000.00
totalOtherIncomeExpenseNet -4147000.00
netIncomeFromContinuingOps -19092000.00
netIncomeApplicableToCommonShares -19092000.00
2018-06-30
date 2018-06-30
currency_symbol USD
researchDevelopment 7913000.00
incomeBeforeTax -18947000.00
netIncome -18947000.00
sellingGeneralAdministrative 9531000.00
ebit -17444000.00
operatingIncome -17444000.00
totalOperatingExpenses 17444000.00
totalOtherIncomeExpenseNet -1503000.00
netIncomeFromContinuingOps -18947000.00
netIncomeApplicableToCommonShares -18947000.00
2018-03-31
date 2018-03-31
currency_symbol USD
researchDevelopment 7913000.00
incomeBeforeTax -18947000.00
netIncome -18947000.00
sellingGeneralAdministrative 9531000.00
ebit -17444000.00
operatingIncome -17444000.00
totalOperatingExpenses 17444000.00
totalOtherIncomeExpenseNet -1503000.00
netIncomeFromContinuingOps -18947000.00
netIncomeApplicableToCommonShares -18947000.00
yearly
2018-12-31
date 2018-12-31
currency_symbol USD
researchDevelopment 35583000.00
incomeBeforeTax -73667000.00
netIncome -73667000.00
sellingGeneralAdministrative 29453000.00
ebit -65036000.00
operatingIncome -65036000.00
interestExpense 0.00
totalOperatingExpenses 65036000.00
totalOtherIncomeExpenseNet -8631000.00
netIncomeFromContinuingOps -73667000.00
netIncomeApplicableToCommonShares -73667000.00
2017-12-31
date 2017-12-31
currency_symbol USD
researchDevelopment 28635000.00
incomeBeforeTax -61084000.00
netIncome -61084000.00
sellingGeneralAdministrative 19626000.00
ebit -48261000.00
operatingIncome -48261000.00
interestExpense 0.00
totalOperatingExpenses 48261000.00
totalOtherIncomeExpenseNet -12823000.00
netIncomeFromContinuingOps -61084000.00
netIncomeApplicableToCommonShares -61084000.00